About Novocardia
Novocardia is a company based in New York (United States) founded in 2020.. Novocardia has raised $53.7 million across 1 funding round from investors including Deerfield. Novocardia offers products and services including Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program. Novocardia operates in a competitive market with competitors including HeartPlace, National Cardiovascular Partners, Cardiovascular Institute of Central Florida, Cardiovascular Associates of Central Florida and Bay Area Cardiology, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cardiovascular Associates Of America
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$53.7 M (USD)
in 1 rounds
-
Latest Funding Round
$53.7 M (USD), Series A
Jun 28, 2021
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novocardia
Novocardia offers a comprehensive portfolio of products and services, including Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supports heart failure patients with monitoring and self-management to prevent hospitalizations.
Manages locations for cost-effective imaging and procedures while maintaining quality.
Facilitates smooth transitions between care settings to reduce unnecessary visits.
Provides prompt specialist appointments for timely cardiovascular care delivery.
Unlock access to complete
Unlock access to complete
Funding Insights of Novocardia
Novocardia has successfully raised a total of $53.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $53.7 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $53.7M
-
First Round
First Round
(28 Jun 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series A - Novocardia | Valuation | Deerfield |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Novocardia
Novocardia has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Novocardia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Novocardia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novocardia Comparisons
Competitors of Novocardia
Novocardia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HeartPlace, National Cardiovascular Partners, Cardiovascular Institute of Central Florida, Cardiovascular Associates of Central Florida and Bay Area Cardiology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A chain of cardiology clinics is operated nationwide.
|
|
| domain | founded_year | HQ Location |
Chain of general clinics
|
|
| domain | founded_year | HQ Location |
Offers cardiology care including diagnosis and treatment of heart conditions.
|
|
| domain | founded_year | HQ Location |
Cardiology practice offering expert cardiovascular care, diagnostics, and imaging
|
|
| domain | founded_year | HQ Location |
Offers cardiology services, diagnostics, and treatments for heart conditions in Florida.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novocardia
Frequently Asked Questions about Novocardia
When was Novocardia founded?
Novocardia was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Novocardia located?
Novocardia is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Novocardia a funded company?
Novocardia is a funded company, having raised a total of $53.7M across 1 funding round to date. The company's 1st funding round was a Series A of $53.7M, raised on Jun 28, 2021.
What does Novocardia do?
Novocardia was founded in 2020 in New York, United States, within the healthcare sector focused on cardiovascular services. Value-based care models are developed and implemented to address heart failure management, site-of-service optimization, and care transition interventions. Technology and analytics are employed to support care coordination, reduce hospitalizations, and enhance operational efficiency. Partnerships with physicians and payers are established across the United States to facilitate better patient outcomes at reduced costs.
Who are the top competitors of Novocardia?
Novocardia's top competitors include National Cardiovascular Partners, Cardiovascular Associates of Central Florida and Daytona Heart Group.
What products or services does Novocardia offer?
Novocardia offers Longitudinal Heart Failure Program, Site-of-Service Management, Care Transitions Intervention, and Same Day Access Program.
Who are Novocardia's investors?
Novocardia has 1 investor. Key investors include Deerfield.